Humana, a titan in the health insurance industry, has continued to demonstrate robust growth, soaring high with an impressive Q2 earnings report that led to a nearly 6% increase in the stock price. This article will dissect the various facets that contributed to this prosperous quarter, including a look at share repurchases, Medicare and Medicaid growth…
Keep reading with a 7-day free trial
Subscribe to The Healthcare Economy to keep reading this post and get 7 days of free access to the full post archives.